In the pharmaceutical industry, outdated technology and fragmented systems have resulted in disjointed processes and increased potential for errors. Particularly in batch review and release, disparate systems hinder efficient data-exchange, leading to delays and inefficiencies. This presentation highlights the need for integrated solutions to enable end-to-end traceability, emphasising the importance of breaking down silos and… Read more »
Latest equipment developments that can see and report microbial bioburden in air and water as it happens, will be presented, with how it fits with Annex 1 compliance explained
Drug development is a lengthy, complex and expensive activity, which leads to a large temporal discrepancy between scientific discoveries and their use in clinics. Intra-target Micro-dosing trials attempt to shorten this delay by delivering a safe, low, non-therapeutic dose directly at the disease site to extract important pharmacodynamic data to assess API efficiency from the… Read more »
Highlighting how Environmental Sustainability is considered in the Pharmaceutical and Health Care Supply Chain whilst maintaining a high standard of service, without compromising compliance. Will also discuss how the transport sector, and more specifically the Pharmaceutical and Healthcare transport sector, must be practical in their approach to Environmental Sustainability as well as also the consideration… Read more »
In the current dynamic landscape of disruptive challenges, ranging from geopolitical tensions to the spectre of inflation, firms are compelled to identify new levers to strengthen their Supply Chains (SC). At the same time, companies are required to pursue a twin transition, i.e. the simultaneous digital and “green” transformation. In this presentation, we will put… Read more »
Organizational culture change is not something that is developed overnight or implemented via a set of instructions, nor is it something that can be changed by minor adjustments to a few people’s behaviors. It takes time and effort. Most importantly, it takes sustained commitment, unwavering dedication to an aligned approach, robust and constructive minimization of… Read more »
Two billion people globally live without access to essential medicines. Healthcare companies want to do more to support communities but can be put off by the labour-intensive processes involved and the compliance risks posed. Introducing, Boaz, a SaaS product that bridges the gap between healthcare companies and NGOs. Boaz makes managing the complexities of the… Read more »
This presentation will cover the Grand Challenge 2 Project (PACE – Pharmaceutical Automation for Clinical Excellence) which will be delivered as POC in 2 months’ time. The key components of this project are: The modular design of PACE which allows, multiple drugs to be manufactured and packaged in the same facility without cross-contamination. Layers of… Read more »